Sunday, September 30, 2018

Mankind Pharma eyes $1 billion topline by FY21

Mankind Pharma eyes $1 billion topline by FY21 The company is also looking at increasing its exports substantially to $100-150 million in the next three years from the present $10 million.

from Moneycontrol Business News https://ift.tt/2Qla994

No comments:

Post a Comment

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...